Glenview Capital Management, LLC
New York, NY 21 processed 13Fs on this site, 2021 Q3 to 2026 Q2
- $5.5B
- 42 holdings
- 2026 Q2
- +37.9% QoQ
- Top 5 39.7%
Glenview Capital Management's biggest moves in 2026 Q2 were opening Agilent Technologies and Eli Lilly, adding to Danaher and Thermo Fisher Scientific, trimming CVS Health and Teva Pharmaceutical Industries, and selling out of DXC Technology and Zoominfo Technologies.
AUM over time
Latest book
| GPN, Global Payments | Add +40.0% | 8,906,709 | $72.56 | $646M | +2,546,317 | +$218M | |
| CVS, CVS Health | Reduce −41.1% | 4,824,799 | $103.45 | $499M | −3,372,000 | −$90M | |
| THC, Tenet Healthcare | Add +46.6% | 2,235,666 | $187.08 | $418M | +710,812 | +$130M | |
| TMO, Thermo Fisher Scientific | Add +150.4% | 627,240 | $501.36 | $314M | +376,715 | +$191M | |
| AMZN, Amazon | Add +20.1% | 1,271,687 | $238.34 | $303M | +212,417 | +$82M | |
| A, Agilent Technologies | New | 1,969,541 | $132.83 | $262M | +1,969,541 | +$262M | |
| DHR, Danaher | Add +633.3% | 1,145,979 | $190.48 | $218M | +989,704 | +$189M | |
| META, Meta Platforms | Add +190.9% | 356,841 | $563.29 | $201M | +234,179 | +$131M | |
| AMD, Advanced Micro Devices | Reduce −54.1% | 298,410 | $580.91 | $173M | −352,382 | +$41M | |
| TEVA, Teva Pharmaceutical Industries | Reduce −23.7% | 5,081,091 | $33.88 | $172M | −1,579,129 | −$28M | |
| VTRS, Viatris | Add +8.7% | 9,877,409 | $15.88 | $157M | +790,165 | +$34M | |
| UBER, Uber | Add +23.2% | 1,793,598 | $72.16 | $129M | +337,726 | +$25M | |
| CNC, Centene | Reduce −41.3% | 1,886,055 | $64.19 | $121M | −1,327,591 | +$16M | |
| BFLY, Butterfly Network | Hold | 14,335,055 | $8.42 | $121M | — | — | |
| CI, Cigna | Reduce −17.4% | 412,223 | $275.68 | $114M | −86,618 | −$19M | |
| HUM, Humana | Reduce −24.1% | 254,216 | $397.22 | $101M | −80,676 | +$43M | |
| XYZ, Block | Reduce −12.3% | 1,197,046 | $76.00 | $91M | −167,425 | +$8.9M | |
| DKS, Dicks Sporting Goods | Add +34.2% | 401,067 | $226.81 | $91M | +102,156 | +$32M | |
| GENI, Genius Sports | Add +57.6% | 13,495,287 | $6.06 | $82M | +4,934,399 | +$44M | |
| ONTO, Onto Innovation | Reduce −31.3% | 205,791 | $378.45 | $78M | −93,930 | +$16M | |
| LLY, Eli Lilly | New | 57,771 | $1,199 | $69M | +57,771 | +$69M | |
| UAL, United Airlines | Reduce −0.4% | 494,736 | $135.99 | $67M | −2,124 | +$22M | |
| EYE, National Vision | Add +98.0% | 3,101,083 | $19.01 | $59M | +1,535,166 | +$18M | |
| CSCO, Cisco | Add +21.6% | 413,332 | $117.46 | $49M | +73,513 | +$22M | |
| ESI, Element Solutions | Reduce −38.9% | 994,579 | $47.75 | $47M | −634,104 | −$8.1M | |
| AMAT, Applied Materials | Reduce −66.9% | 65,201 | $723.00 | $47M | −132,008 | −$20M | |
| MKSI, MKS | New | 98,532 | $444.80 | $44M | +98,532 | +$44M | |
| FUN, Six Flags Entertainment | Reduce −9.2% | 2,017,821 | $21.30 | $43M | −205,328 | +$3.5M | |
| STM, Stmicroelectronics | New | 560,060 | $74.89 | $42M | +560,060 | +$42M | |
| ABBV, AbbVie | New | 148,913 | $251.64 | $37M | +148,913 | +$37M | |
| AZN, AstraZeneca | New | 184,279 | $189.62 | $35M | +184,279 | +$35M | |
| BLCO, Bausch Plus Lomb | Add +0.4% | 1,918,148 | $16.56 | $32M | +7,652 | +$1.4M | |
| BKR, Baker Hughes | Add +62.5% | 493,519 | $55.50 | $27M | +189,844 | +$8.9M | |
| ELV, Elevance Health | New | 66,599 | $386.73 | $26M | +66,599 | +$26M | |
| MCHP, Microchip Technology | New | 265,577 | $91.20 | $24M | +265,577 | +$24M | |
| BRKR, Bruker | New | 252,169 | $60.18 | $15M | +252,169 | +$15M | |
| NVS, Novartis | New | 86,909 | $156.72 | $14M | +86,909 | +$14M | |
| DOCN, Digitalocean | Reduce −66.1% | 84,812 | $157.03 | $13M | −165,188 | −$8.1M | |
| PRMB, Primo Brands | Reduce −23.7% | 404,971 | $24.44 | $9.9M | −126,080 | −$102K | |
| BSX, Boston Scientific | New | 113,096 | $42.68 | $4.8M | +113,096 | +$4.8M | |
| CAH, Cardinal Health | New | 18,018 | $237.56 | $4.3M | +18,018 | +$4.3M | |
| TECH, Bio-Techne | Reduce −68.7% | 58,324 | $70.65 | $4.1M | −127,988 | −$5.6M |
Exits / last held
Gone since 2026 Q1, shown at their last reported size.
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| DXC, DXC Technology | Exit | 0 | $12.57 | $112M | −8,895,875 | −$112M | |
| GTM, Zoominfo Technologies | Exit | 0 | $5.98 | $95M | −15,905,242 | −$95M | |
| USFD, US Foods | Exit | 0 | $92.21 | $35M | −384,007 | −$35M | |
| Z, Zillow | Exit | 0 | $41.38 | $33M | −789,670 | −$33M | |
| LAD, Lithia Motors | Exit | 0 | $249.72 | $32M | −127,605 | −$32M | |
| LION, Lionsgate Studios | Exit | 0 | $9.59 | $27M | −2,778,781 | −$27M | |
| MYGN, Myriad Genetics | Exit | 0 | $4.50 | $24M | −5,411,978 | −$24M | |
| SGRY, Surgery Partners | Exit | 0 | $11.92 | $21M | −1,800,000 | −$21M | |
| AKAM, Akamai | Exit | 0 | $114.85 | $18M | −156,453 | −$18M | |
| INTC, Intel | Exit | 0 | $44.13 | $18M | −399,506 | −$18M | |
| BIIB, Biogen | Exit | 0 | $183.32 | $10M | −57,019 | −$10M |
Filings history
20 periods, with AUM normalized
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 45 | $5.5B | +37.9% | 13F-HR | 8/14/2026 | 000090514826003712 |
| 2026 Q1 | 44 | $4B | −18.9% | 13F-HR | 5/15/2026 | 000090514826002354 |
| 2025 Q4 | 57 | $4.9B | +9.4% | 13F-HR | 2/17/2026 | 000090514826000846 |
| 2025 Q3 | 54 | $4.5B | +25.8% | 13F-HR | 11/14/2025 | 000090514825004016 |
| 2025 Q2 | 43 | $3.6B | −12.2% | 13F-HR | 8/14/2025 | 000090514825002959 |
| 2025 Q1 | 45 | $4.1B | +2.8% | 13F-HR | 5/15/2025 | 000090514825001735 |
| 2024 Q4 | 36 | $4B | −23.5% | 13F-HR | 2/14/2025 | 000090514825000645 |
| 2024 Q3 | 46 | $5.2B | +1.7% | 13F-HR | 11/14/2024 | 000090514824003140 |
| 2024 Q2 | 48 | $5.1B | −11.2% | 13F-HR | 8/14/2024 | 000090514824002216 |
| 2024 Q1 | 45 | $5.7B | +22.3% | 13F-HR | 5/15/2024 | 000090514824001435 |
| 2023 Q4 | 44 | $4.7B | +5.9% | 13F-HR | 2/14/2024 | 000090514824000708 |
| 2023 Q3 | 52 | $4.4B | −0.5% | 13F-HR | 11/14/2023 | 000090514823001439 |
| 2023 Q2 | 49 | $4.4B | −2.7% | 13F-HR | 8/14/2023 | 000090514823000724 |
| 2023 Q1 | 54 | $4.6B | +1.0% | 13F-HR | 5/15/2023 | 000090514823000429 |
| 2022 Q4 | 53 | $4.5B | +12.9% | 13F-HR | 2/14/2023 | 000090514823000237 |
| 2022 Q3 | 54 | $4B | +0.1% | 13F-HR | 11/14/2022 | 000156761922020011 |
| 2022 Q2 | 55 | $4B | −19.1% | 13F-HR | 8/11/2022 | 000156761922015586 |
| 2022 Q1 | 60 | $4.9B | +5.3% | 13F-HR | 5/16/2022 | 000156761922011005 |
| 2021 Q4 | 57 | $4.7B | −14.1% | 13F-HR | 2/14/2022 | 000156761922004451 |
| 2021 Q3 | 2 | $55M | — | new holds | 2/18/2022 | 000156761922005142 |
| 2021 Q3 | 59 | $5.5B | — | 13F-HR | 11/15/2021 | 000156761921020478 |
About
Glenview Capital Management, LLC
21 processed 13Fs on this site, 2021 Q3 to 2026 Q2